Clinical Trial Update: Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe [Phase 2]

View source ↗

Summary

Phase 2 trial assessing user handling of the BI 695501 autoinjector in rheumatoid arthritis, with an extension phase using a prefilled syringe to compare admini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BI 695501

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2017-10-06